Treatment of Patients at High Risk for Recurrent Bleeding from a Peptic Ulcer

@article{Jensen2003TreatmentOP,
  title={Treatment of Patients at High Risk for Recurrent Bleeding from a Peptic Ulcer},
  author={D. Jensen},
  journal={Annals of Internal Medicine},
  year={2003},
  volume={139},
  pages={294-295}
}
  • D. Jensen
  • Published 2003
  • Medicine
  • Annals of Internal Medicine
  • The management of patients with severe ulcer hemorrhage is rapidly changing. A decade ago, physicians called a general surgeon for upper gastrointestinal hemorrhage. Now, they call an endoscopist (usually a gastroenterologist) to assist in initial management (1). Although some use clinical criteria, such as Rockall scores (2), to triage patients to different levels of hospital care, the current standard of care is early panendoscopy to establish a specific diagnosis, identify predictors of more… CONTINUE READING
    13 Citations
    Endoscopic treatment of ulcer bleeding
    • 25

    References

    SHOWING 1-10 OF 16 REFERENCES
    Recurrent bleeding from peptic ulcer associated with adherent clot: a randomized study comparing endoscopic treatment with medical therapy.
    • 156
    Randomized trial of medical or endoscopic therapy to prevent recurrent ulcer hemorrhage in patients with adherent clots.
    • 200
    Endoscopic hemostasis. An effective therapy for bleeding peptic ulcers.
    • 312
    The evolution of stigmata of hemorrhage in bleeding peptic ulcers: a sequential endoscopic study.
    • 121
    Nature of the bleeding vessel in recurrently bleeding gastric ulcers.
    • 218
    Risk assessment after acute upper gastrointestinal haemorrhage.
    • 1,137
    • PDF
    Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers.
    • 568
    • Highly Influential
    • PDF
    Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis.
    • 708
    The Effect of Endoscopic Therapy in Patients Receiving Omeprazole for Bleeding Ulcers with Nonbleeding Visible Vessels or Adherent Clots
    • 160
    • Highly Influential
    Bleeding peptic ulcer.
    • 543